Last reviewed · How we verify

NCT05900830

Therapy Program for Academic Skills in Children With Intellectual Disability

Completed NA Last updated 12 November 2024
What this trial tests

NA trial testing play therapy in Intellectual Disability, Mild in 20 participants. Completed in 5 February 2023.

Timeline
15 November 2022
Primary endpoint
30 January 2023
5 February 2023

Quick facts

Lead sponsorBeni-Suef University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment20
Start date15 November 2022
Primary completion30 January 2023
Estimated completion5 February 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 8 to 10, any sex, with Intellectual Disability, Mild or Educational Problems. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of a physical and occupational therapy program on academic skills in a sample of Egyptian children with intellectual disability. It also aims to provide a program based on physical and occupational therapy activities and techniques to develop children's basic abilities through play to make learning more enjoyable

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of play therapy

Trials testing the same drug.

Other recruiting trials for Intellectual Disability, Mild

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05900830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing